REFERENCES

STUDY REPORTS

- Pharmaceuticals: Interactive cost-utility Markov-Microsimulation model (MCMC) with Excel®, pathology: Venous leg ulcer, diabetic foot ulcer. Interactive budget impact model with Excel®

- Pharmaceuticals: Interactive cost-utility Markov model with Excel®, pathology: Severe aortic stenosis (SAS).

- Pharmaceuticals: Bayesian multi-treatment meta-analysis with Winbugs/R, pathology: Severe aortic stenosis (SAS).

 

 Pharmaceuticals: Bayesian multi-treatment meta-analysis, interactive cost-utility Markov model with Excel®, pathology: Severe aortic stenosis (SAS).

University Hospital Center: Medico-economic evaluation in real life of an innovative organization with R and Excel®, pathology: Diabetes (Erasmus Health Insurance data, CHU data).

University Hospital Center: Medico-economic model of an antiseptic solution for the prevention of catheter infections in intensive care units, with R and Excel®.

Pharmaceuticals: Markov cost-utility model under Excel®, pathology: Severe asthma.

Pharmaceuticals: Excel® budget impact interactive model, pathology: Severe asthma.

Pharmaceuticals: Markov cost-utility model under Excel®, pathology: Chronic Hepatitis C.

University Hospital Center: Pathology cost study in Excel®, pathology: COPD. Cost-effective Markov model under R and Excel®, pathology: COPD. Excel® budget impact model, pathology: COPD

Pharmaceuticals: Cost-utility Markov model under Excel®, pathology: Chronic Hepatitis C. Excel® interactive budget impact model, pathology: Chronic Hepatitis C.

Pharmaceuticals: Cost-effective prospective evaluation of a therapeutic innovation in the prevention of catheter infection in intensive care unit: Markov model not homogeneous on several catheters and several infections, under Excel®.

Pharmaceuticals: Realization of a budgetary impact model with user interface of the progressive diffusion of a therapeutic innovation in the treatment of actinic keratosis: Markov model on dynamic cohort under Excel®.

Pharmaceuticals: Cost-effectiveness evaluation of a therapeutic innovation in the treatment of actinic keratosis: Excel® decision tree model.

Pharmaceuticals: Realization of a multi-treatment meta-analysis (under Winbugs and R) evaluating the comparative effectiveness of a therapeutic innovation in the treatment of actinic keratosis.

Pharmaceuticals: Statistical analysis of a database on psoriasis. Study of compliance with prescriptions, comorbidities, quality of life and economic aspects.

Pharmaceuticals: Excel® interactive budget impact model of the progressive diffusion of a therapeutic innovation in the management of venous leg ulcers.

Pharmaceuticals:

Cost-effectiveness Markov model with Excel®

French Ministry of Health:
Developing a disease model compensation for one pathology from an international study.

 Regional Health Insurance in Midi-Pyrénées:

External assessment of the regional health network DIAMIP, in diabetes melitus. Study funded by the Fund Intervention for Quality and Coordination Care (FIQCS Midi-Pyrénées).

Participation in research for SFDRMG
(French Society for Documentation and Research for General Practice):
Assessing the impact of the use of reminders
IT for improving health Professional practice (URIAP study).

Regional Health Insurance in Ile-de-France: Assessing the satisfaction of health professionals awareness by the model of private practice grouped in two cities in the Ile-de-France.

ARIANE 72 RSP network, a network of palliative care in Sarthe:
Survey of quality of life and satisfaction caregivers (relatives, family friends) in the under management by the network. A satisfaction survey of concerned physicians was also planned. A survey of key network partners (hospitals, institutions, etc.) was also performed and this study aimed to assess the particular positioning system 72 in its Ariane professional environment  (medical, medico-Social and institutional). This study was funded by Regional Health Insurance in Pays de la Loire.

Regional Health Insurance in Auvergne:
External evaluation of three health Diabetes networks funded by Intervention Fund for Quality and Care Coordination.

Fravimed:
Performing a mathematical model of budgetary impact (public hospital perspective) for an innovative device in Neurosurgery (Markovian decision Process).

Diabetes Network in Trégor:
External assessment of the Health Network in
diabetes melitus.

Diabetes Network in Normandie:
Qualitative impact assessment of the health network, satisfaction of patients, health professionals and partners network (associations, other networks,
hospitals, etc.).

Grouping Redeployment Project Implementation (RIR Association Ile de France):
Assessment of the efficiency of the proposed association RIR-IDF, which received financial support from the Fund Aid for Quality Care City (Ile-De-France), to conduct feasibility studies and implementation of consolidation exercises of various health professionals.

Ministry of Health:
Medico-economic study of the care pathway of patients with hepatitis C, excluding complication of cirrhosis and cancer.

PRIORY network, local network for continued care at home: Medico-economic external assessment of PRIORY.

The network
PRIORY provides the patient with a severe or progressive disease, a situation
dependency or disability, the possibility of staying at home if the desire is expressed. It offers comprehensive and interdisciplinary and coherent care around the general practitioner.

FaLang translation system by Faboba
top arrow